a cross-over design was employed that consisted of three parts : a single intravenous dose ( 0.1 mg/kg ) , and oral dosing ( 10 mg/day ) for six days followed by an intravenous bolus ( 0.1 mg/kg ) on the seventh day , followed by re-examination of a single intravenous dose after diazepam ( d ) and its major metabolite desmethyldiazepam ( dd ) had been completely eliminated .
C0012010
diazepam
C0011279
desmethyldiazepam